Research programme: breast cancer therapeutic lentivirus - American Gene Technologies
Latest Information Update: 13 Sep 2023
Price :
$50 *
At a glance
- Originator American Gene Technologies International
- Class Gene therapies
- Mechanism of Action Cell division inhibitors; Gene transference
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Preclinical Breast cancer